Center-Authored Papers

Filters: Author is Rodler, Eve  [Clear All Filters]
B
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
C
Chang AE, Chai X, Pollack SM, Loggers E, Rodler E, Dillon J, Parvathaneni U, Moe KS, Futran N, Jones RL.  2014.  Analysis of clinical prognostic factors for adult patients with head and neck sarcomas.. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 151(6):976-83. Abstract
Constantinidou A, Pollack S, Loggers E, Rodler E, Jones RL.  2013.  The evolution of systemic therapy in sarcoma.. Expert review of anticancer therapy. 13(2):211-23. Abstract
P
Pollack SM, Li Y, Blaisdell MJ, Farrar EA, Chou J, Hoch BL, Loggers ET, Rodler E, Eary JF, Conrad EU et al..  2012.  NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.. PloS one. 7(2):e32165. Abstract
Pollack SM, Jungbluth AA, Hoch BL, Farrar EA, Bleakley M, Schneider DJ, Loggers ET, Rodler E, Eary JF, Conrad EU et al..  2012.  NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.. Cancer. 118(18):4564-70. Abstract
R
Rodler E, Korde L, Gralow JR.  Submitted.  Current Treatment Options in Triple Negative Breast Cancer.. Breast disease. 32(1-2):99-112. Abstract